http://www.fpnotebook.com/
Pheochromocytoma
Aka: Pheochromocytoma, Paroxysmal Hypertension- Definition
- Catecholamine secreting tumor of the Adrenal Gland
- Epidemiology
- Presentation: Classic Episodes
- Predominant Symptoms
- Headache
- Diaphoresis or Sweating
- Palpitations
- Associated Symptoms
- Anxiety
- Tremor
- Pallor
- Chest Pain
- Epigastric Pain
- Flushing (rare)
- Painless Hematuria (rare)
- Timing of episodes
- Duration: One hour or less
- Frequency: daily to once every few months
- Predominant Symptoms
- Presentation: Other
- Hyperadrenergic spells (see classic episodes above)
- Resistant Hypertension
- Malignant or intra-operative Hypertension
- Family History of Pheochromocytoma or predisposing syndromes (e.g. MEN 2, NF1, VHL. SDH)
- Premature Hypertension (age under 20 years)
- Idiopathic Dilated Cardiomyopathy
- Diagnostic Clues
- Six "H's"
- Hypertension
- Headache - throbbing (90%)
- Hyperhidrosis or excessive sweating (69%)
- Heart consciousness or Palpitations (73%)
- Hypermetabolism
- Hyperglycemia
- Rule of 10
- Familial (10%)
- Malignant (10%)
- Multiple or Bilateral (10%)
- Extra-adrenal (10%)
- Childhood onset (10%)
- Recurrence after Surgery (10%)
- Six "H's"
- Differential Diagnosis
- Primary Aldosteronism
- Carcinoid
- Accelerated or Malignant Hypertension
- Illicit, OTC or prescribed Sympathomimetic medications
- Chemodectoma
- Ganglioneuroma
- Thyrotoxicosis
- Menopause
- Panic Disorder
- Antihypertensive withdrawal (e.g. Clonidine withdrawal)
- Labs: Preparation
- Stop any interfering medications
- Labetalol (stop for 1 week)
- Tricyclic Antidepressant (stop for 2 weeks)
- Psychoactive medications (stop for weeks)
- Levodopa or Methyldopa
- Decongestants
- Benzodiazepines
- Muscle relaxants (mephenasin, Methocarbamol)
- Avoid Tylenol for 48 hours
- Avoid Aspirin
- Stop other interfering agents
- Stop any interfering medications
- Labs: Available Tests
- Best studies
- Urine Metanephrines (24 hour collections)
- Use as first line screening
- Test Sensitivity: 76%
- Test Specificity: 94%
- Plasma Free Metanephrines
- Very high false positive rate (Pheochromocytoma is rare)
- Use only for confirmation, not for screening
- Test Sensitivity: 99%
- Test Specificity: 89%
- Urine Metanephrines (24 hour collections)
- Tests with lower efficacy
- Urinary VMA
- Normal value under 6.5 mg/day
- Imprecise test
- Drugs and food interfere with test
- Test Sensitivity: 63%
- Test Specificity: 94%
- Plasma Catecholamines (Norepinephrine, Epinephrine)
- Test Sensitivity: 85%
- Test Specificity: 80%
- Urinary VMA
- Best studies
- Labs: Protocol
- First: 24-hour Urine Metanephrine and Urine VMA
- Next: Plasma Free Metanephrines
- Next: Plasma Catecholamines (equivocal metanephrines)
- Final: Clonidine Suppression (positive Catecholamines)
- Radiology: Tumor localization
- Adrenal CT or Adrenal MRI
- Test Sensitivity: 93 to 100%
- Test Specificity: 70%
- MIGB Scan (metaiodobenzyl-guanidine)
- Test Sensitivity: 77 to 90%
- Test Specificity: 95 to 100%
- Good for looking for tumors in unusual places
- Adrenal CT or Adrenal MRI
- Management
- Preoperative Medical Management
- Alpha Adrenergic Receptor antagonist (2 weeks pre-op)
- Phenoxybenzamine PO bid
- Phentolamine IV prn
- Beta Blocker (only start after alpha blockade)
- Propranolol PO qid
- Alpha Adrenergic Receptor antagonist (2 weeks pre-op)
- Surgical Management
- Laparoscopic adrenalectomy Indications
- Single, small adrenal tumors
- Hypertension controlled
- Open Adrenalectomy
- Adrenal tumor size over 7 cm
- Laparoscopic adrenalectomy Indications
- Intra-Operative Management
- Continuous Arterial-line Blood Pressure Monitoring
- Treat Hypotension
- Fluid management
- Consider pressor support
- Treat Hypertension
- Phentolamine
- Nitroprusside
- Treat Tachycardia or ectopy
- Adjunctive treatment for malignant Pheochromocytoma
- Chemotherapy
- Cyclophosphamide
- Dacarbazine
- Vincristine
- MIGB (metaiodobenzyl-guanidine I-131)
- Metyrosine 1 gram every 6 hours
- Depletes tumor Catecholamine stores
- Chemotherapy
- Preoperative Medical Management
- Course
- Persistent Hypertension in 25% of treated patients
- Monitoring
- Screen Urine Metanephrines annually
- Screen Urine Catecholamines annually
- References
- Bailey (2001) CMEA Medicine Lecture, San Diego
- (Feb 2001) Ann Intern Med